🇺🇸 Providone-Iodine in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 27

Most-reported reactions

1. Platelet Count Decreased — 4 reports (14.81%)
2. Alanine Aminotransferase Increased — 3 reports (11.11%)
3. Anaemia — 3 reports (11.11%)
4. Drug Effect Decreased — 3 reports (11.11%)
5. Erythema — 3 reports (11.11%)
6. Pyrexia — 3 reports (11.11%)
7. Aspartate Aminotransferase Increased — 2 reports (7.41%)
8. Blood Lactate Dehydrogenase Increased — 2 reports (7.41%)
9. Body Temperature Decreased — 2 reports (7.41%)
10. C-Reactive Protein Increased — 2 reports (7.41%)

Source database →

Frequently asked questions

Is Providone-Iodine approved in United States?

Providone-Iodine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Providone-Iodine in United States?

iRenix Medical, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.